Showing results (71-80 of 200) with videos related to
Sort By:
Pageof 20
Mutation Research|November 11, 2008
Analysis of a set of missense, frameshift, and in-frame deletion variants of BRCA1Marcelo Carvalho, Maria A Pino, Rachel Karchin, et al.Human Mutation|October 23, 2009
Evaluation of SNPs in miR-146a, miR196a2 and miR-499 as low-penetrance alleles in German and Italian familial breast cancer casesIrene Catucci, Rongxi Yang, Paolo Verderio, et al.International Journal of Cancer|January 8, 2019
Insight into genetic susceptibility to male breast cancer by multigene panel testing: Results from a multicenter study in ItalyPiera Rizzolo, Veronica Zelli, Valentina Silvestri, et al.European Journal of Cancer (Oxford, England : 1990)|August 8, 2015
Novel and known genetic variants for male breast cancer risk at 8q24.21, 9p21.3, 11q13.3 and 14q24.1: results from a multicenter study in ItalyValentina Silvestri, Piera Rizzolo, Marco ScarnĂ², et al.BMJ Open|May 16, 2025
Impact of comprehensive genomic profiling and molecular tumour board on costs and access to tailored therapies: real-world observational studyValentina De Micheli, Luca Agnelli, Elena Conca, et al.European Journal of Cancer (Oxford, England : 1990)|June 1, 2023
Male breast cancer risk associated with pathogenic variants in genes other than BRCA1/2: an Italian case-control studyAgostino Bucalo, Giulia Conti, Virginia Valentini, et al.Tumori|September 23, 2024
Is tumour sequencing effective for the identification of germline BRCA1/2 pathogenic variant carriers?Jacopo Azzollini, Iolanda Capone, Matteo Duca, et al.Tumori|March 25, 2023
Treating secondary malignant neoplasms: A burden of childhood cancer survivorsMarta G Podda, Cristina Meazza, Giovanna Gattuso, et al.JCO Precision Oncology|June 11, 2025
Real-World Outcomes of Molecular Tumor Board Treatment RecommendationsFederico Nichetti, Marta Brambilla, Matteo Duca, et al.Breast Cancer Research and Treatment|June 22, 2014
Duration of tamoxifen use and the risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriersJacek Gronwald, Andre Robidoux, Charmaine Kim-Sing, et al.Pageof 20